May 20 (Reuters) - BioMarin Pharmaceutical (BMRN.O), opens new tab said on Wednesday its treatment for a rare condition that leads to short stature helped ‌boost growth in children, meeting the main ...
Feb 12 (Reuters) - BridgeBio Pharma (BBIO.O), opens new tab said its experimental therapy boosted growth rates in children with a rare genetic disorder that causes dwarfism, sending the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results